Similarly, elevated ABCC3 expression in lung cancer cells has been associated with reduced sensitivity to chemotherapeutic agents such as methotrexate, doxorubicin, vincristine, etoposide, and cisplatin [36,37]. This evidence concerns the gene ABCC3 and lung cancer.